NO20000992L - FremgangsmÕter som benytter fag-display for Õ seleksjon av internaliserende ligander for genavlevering - Google Patents

FremgangsmÕter som benytter fag-display for Õ seleksjon av internaliserende ligander for genavlevering

Info

Publication number
NO20000992L
NO20000992L NO20000992A NO20000992A NO20000992L NO 20000992 L NO20000992 L NO 20000992L NO 20000992 A NO20000992 A NO 20000992A NO 20000992 A NO20000992 A NO 20000992A NO 20000992 L NO20000992 L NO 20000992L
Authority
NO
Norway
Prior art keywords
selection
methods
phage display
gene delivery
internalizing ligands
Prior art date
Application number
NO20000992A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000992D0 (no
Inventor
David Larocca
Original Assignee
Selective Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Selective Genetics Inc filed Critical Selective Genetics Inc
Publication of NO20000992D0 publication Critical patent/NO20000992D0/no
Publication of NO20000992L publication Critical patent/NO20000992L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
NO20000992A 1997-08-29 2000-02-28 FremgangsmÕter som benytter fag-display for Õ seleksjon av internaliserende ligander for genavlevering NO20000992L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5706797P 1997-08-29 1997-08-29
PCT/US1998/017949 WO1999010485A1 (fr) 1997-08-29 1998-08-28 Procedes utilisant une presentation de phage pour selectionner des ligands internalisants en vue d'une administration de gene

Publications (2)

Publication Number Publication Date
NO20000992D0 NO20000992D0 (no) 2000-02-28
NO20000992L true NO20000992L (no) 2000-03-27

Family

ID=22008306

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000992A NO20000992L (no) 1997-08-29 2000-02-28 FremgangsmÕter som benytter fag-display for Õ seleksjon av internaliserende ligander for genavlevering

Country Status (8)

Country Link
US (1) US6472146B1 (fr)
EP (1) EP1009819A1 (fr)
JP (1) JP2001513995A (fr)
AU (1) AU740541B2 (fr)
CA (1) CA2302292A1 (fr)
NO (1) NO20000992L (fr)
RU (1) RU2234530C2 (fr)
WO (1) WO1999010485A1 (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6443974B1 (en) 1996-07-28 2002-09-03 Biosense, Inc. Electromagnetic cardiac biostimulation
CA2302292A1 (fr) 1997-08-29 1999-03-04 Selective Genetics, Inc. Procedes utilisant une presentation de phage pour selectionner des ligands internalisants en vue d'une administration de gene
US6451527B1 (en) * 1997-08-29 2002-09-17 Selective Genetics, Inc. Methods using genetic package display for selecting internalizing ligands for gene delivery
US6589730B1 (en) 1997-08-29 2003-07-08 Selective Genetics, Inc. Methods for identifying protein-protein interactions by selective transduction
US6723512B2 (en) * 1997-08-29 2004-04-20 Selective Genetics Inc. Methods using genetic package display for detecting and identifying protein-protein interactions that facilitate internalization and transgene expression and cells or tissues competent for the same and methods for evolving gene delivery vectors
US6054312A (en) 1997-08-29 2000-04-25 Selective Genetics, Inc. Receptor-mediated gene delivery using bacteriophage vectors
ES2255155T3 (es) 1998-02-05 2006-06-16 Biosense Webster, Inc. Dispositivo para la administracion intracardiaca de farmacos.
GB9908195D0 (en) * 1999-04-09 1999-06-02 Microbiological Res Authority Treatment of intracellular infection
AU7473500A (en) * 1999-09-01 2001-03-26 University Of Pittsburgh Identification of peptides that facilitate uptake and cytoplasmic and/or nucleartransport of proteins, dna and viruses
SE0000597D0 (sv) * 2000-02-24 2000-02-24 Active Biotech Ab Novel antibody
US20010041349A1 (en) * 2000-04-17 2001-11-15 Andrew Patron Protein expression system arrays and use in biological screening
AU2001278968A1 (en) * 2000-07-19 2002-01-30 Pointilliste, Inc. Nested sorting and high throughput screening
US7045283B2 (en) 2000-10-18 2006-05-16 The Regents Of The University Of California Methods of high-throughput screening for internalizing antibodies
US7091046B2 (en) 2000-12-11 2006-08-15 Hk Pharmaceuticals, Inc. Multiplexed protein expression and activity assay
GB0115385D0 (en) * 2001-06-22 2001-08-15 Regma Biotechnologies Ltd Novel preparation
US20030143612A1 (en) * 2001-07-18 2003-07-31 Pointilliste, Inc. Collections of binding proteins and tags and uses thereof for nested sorting and high throughput screening
AU2003205186A1 (en) * 2002-01-16 2003-09-02 Regents Of The University Of California Functional ligand display
EP1474504A2 (fr) * 2002-01-24 2004-11-10 Pointilliste, Inc. Utilisation de collections de sites de liaison pour etablir des profils d'echantillons et autres applications
JP2005325055A (ja) * 2004-05-14 2005-11-24 Peptide Door Co Ltd リガンド結合タンパク質含有複合体及びリガンド結合タンパク質に結合する物質のスクリーニング方法
US20080124355A1 (en) 2006-09-22 2008-05-29 David Gordon Bermudes Live bacterial vaccines for viral infection prophylaxis or treatment
RU2009124649A (ru) 2006-12-12 2011-01-20 Морфосис Аг (De) Интернализация
US8647642B2 (en) 2008-09-18 2014-02-11 Aviex Technologies, Llc Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment
US8241623B1 (en) 2009-02-09 2012-08-14 David Bermudes Protease sensitivity expression system
SG173627A1 (en) 2009-02-13 2011-09-29 Chem Inc X Methods of creating and screening dna-encoded libraries
WO2010094027A1 (fr) * 2009-02-13 2010-08-19 X-Body, Inc. Identification de véhicules d'administration d'acides nucléiques faisant appel à l'affichage adn
RU2422520C1 (ru) * 2009-11-30 2011-06-27 Федеральное государственное учреждение здравоохранения "Ростовский-на-Дону ордена Трудового Красного Знамени научно-исследовательский противочумный институт" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека Способ получения и регистрации меченых бактериофагов на модели холерных вибрионов
US8771669B1 (en) 2010-02-09 2014-07-08 David Gordon Bermudes Immunization and/or treatment of parasites and infectious agents by live bacteria
US9597379B1 (en) 2010-02-09 2017-03-21 David Gordon Bermudes Protease inhibitor combination with therapeutic proteins including antibodies
US8524220B1 (en) 2010-02-09 2013-09-03 David Gordon Bermudes Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
RU2425872C1 (ru) * 2010-04-21 2011-08-10 Федеральное государственное учреждение здравоохранения "Ростовский-на-Дону ордена Трудового Красного Знамени научно-исследовательский противочумный институт" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека ШТАММ БАКТЕРИЙ Yersinia enterocolitica, ИСПОЛЬЗУЕМЫЙ В КАЧЕСТВЕ ИНДИКАТОРНОЙ КУЛЬТУРЫ ДЛЯ ВЫЯВЛЕНИЯ УМЕРЕННЫХ БАКТЕРИОФАГОВ ЛИЗОГЕННЫХ ШТАММОВ О1, О3, О12 СЕРОВАРОВ
DK2748357T3 (en) 2011-09-07 2018-07-16 X Chem Inc Methods for labeling DNA-encoded libraries
KR102146721B1 (ko) 2012-07-13 2020-08-21 엑스-켐, 인크. 폴리머라제에 의해 판독가능하지 않은 코딩 올리고뉴클레오티드 연결을 갖는 dna-코딩된 라이브러리
US9593339B1 (en) 2013-02-14 2017-03-14 David Gordon Bermudes Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment
US9737592B1 (en) 2014-02-14 2017-08-22 David Gordon Bermudes Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
EP3577258B1 (fr) * 2017-01-31 2024-11-27 48Hour Discovery Inc. Présentation de molécules sur des nanosupports génétiquement codés silencieusement pour déterminer des interactions moléculaires synergiques
US12391939B2 (en) 2018-07-23 2025-08-19 The Governors Of The University Of Alberta Genetically-encoded bicyclic peptide libraries
WO2020180971A1 (fr) * 2019-03-04 2020-09-10 The Texas A&M University System Procédés de fabrication et d'utilisation de bibliothèques d'affichage de bactériophages à ambre imposé

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2139598T3 (es) * 1990-07-10 2000-02-16 Medical Res Council Procedimientos para la produccion de miembros de parejas de union especifica.
US5733731A (en) 1991-10-16 1998-03-31 Affymax Technologies N.V. Peptide library and screening method
US5516637A (en) * 1994-06-10 1996-05-14 Dade International Inc. Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
WO1997000271A1 (fr) * 1995-06-14 1997-01-03 The Regents Of The University Of California Nouveaux anticorps humains a forte affinite diriges contre des antigenes tumoraux
GB9516138D0 (en) * 1995-08-05 1995-10-04 Medical Res Council Improvements in or relating to methods of screening substances
AU3737297A (en) 1996-08-05 1998-02-25 Brigham And Women's Hospital Bacteriophage-mediated gene therapy
US5955275A (en) * 1997-02-14 1999-09-21 Arcaris, Inc. Methods for identifying nucleic acid sequences encoding agents that affect cellular phenotypes
WO1998039482A1 (fr) 1997-03-07 1998-09-11 Sunol Molecular Corporation Proteines de fusion comprenant une proteine bacteriophage de revetement et un recepteur de cellule a chaine unique
CA2302292A1 (fr) 1997-08-29 1999-03-04 Selective Genetics, Inc. Procedes utilisant une presentation de phage pour selectionner des ligands internalisants en vue d'une administration de gene

Also Published As

Publication number Publication date
RU2234530C2 (ru) 2004-08-20
EP1009819A1 (fr) 2000-06-21
NO20000992D0 (no) 2000-02-28
JP2001513995A (ja) 2001-09-11
CA2302292A1 (fr) 1999-03-04
AU740541B2 (en) 2001-11-08
US6472146B1 (en) 2002-10-29
AU9039898A (en) 1999-03-16
WO1999010485A1 (fr) 1999-03-04

Similar Documents

Publication Publication Date Title
NO20000992D0 (no) Fremgangsmõter som benytter fag-display for õ seleksjon av internaliserende ligander for genavlevering
NO20004523L (no) Avleveringssystem for Õ modulere immunrespons
DE69804609D1 (de) Spender mit zähleinrichtung der dosiseinheiten
ATE450139T1 (de) Verbesserter tropfbewässerungsauslass
DE69839370D1 (de) Einlass für Medikamenteninfusionspumpe
FI963217A7 (fi) Nestemäinen oftalminen, hidastetusti vapauttava antosysteemi
DE69823784D1 (de) Spender für streichfähige produkte
AU3910400A (en) Graph-based visual navigation through spatial environments
AU2001234746A1 (en) Sustained-release microencapsulated delivery system
MXPA02009326A (es) Sistema exhibidor de panel de mercancia.
DE60014589D1 (de) System zur interaktiven verteilung von wählbaren vorstellungen
DE69833808D1 (de) Interaktive Zeitspannenanzeige
FI972866L (fi) Kaksoisnestesuutin
PT1207867E (pt) Formas de administracao farmaceuticas orais retardadas contendo tramadol
DE69813961D1 (de) Plasmaanzeige
NO20002478D0 (no) Apparat for utdeling av fluid
DK1023268T3 (da) Isoquinoliner som urokinaseinhibitorer.
DE59812804D1 (de) Spender für Medien
FI981968L (fi) Nousuputken riippuva kannatus
NO20001523D0 (no) Fremgangsmåte for fremstilling av flytende hydrokarboner
DE60018461D1 (de) Fluidunterstützender teilchenspender
NO974277D0 (no) Dyse for væskeavgivelse
IT1296524B1 (it) Espositore per elementi ruotanti
IT1287701B1 (it) Cavalletto con o senza ruote per secchio portastrizzatore.
FI972373A0 (fi) Foerfarande foer reglering av hastigheten hos en hiss och hissystem

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application